The information provided pursuant to this Item 2.02 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any filing or other document filed by the Company pursuant to the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document. The information furnished pursuant to this Item 2.02 shall instead be deemed “furnished.”

On November 5, 2009, Cell Therapeutics, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2009 and certain other information. The full text of the press release is set forth in Exhibit 99.1 hereto.

(d) Exhibits.

The following exhibit is furnished with this report on Form 8-K:

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

2

EXHIBIT INDEX

3